{"title":"4 ． Research Use of Public Health and Medical Data Using the “Healthcare Data Integration System” Promoted by Kobe City Government","authors":"R. Miki, Hiroki Takahara","doi":"10.3820/jjpe.27.25","DOIUrl":"https://doi.org/10.3820/jjpe.27.25","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87172914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"2 ． Overview of the DeSC Database and Utilization for Clinical Epidemiology and Pharmacoepidemiology Research","authors":"Akira Okada, H. Yasunaga","doi":"10.3820/jjpe.27.11","DOIUrl":"https://doi.org/10.3820/jjpe.27.11","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"05 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85848320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"5 ． Taking Advantage of the Global RWD Standard ―OMOP CDM and OHDSI―","authors":"T. Hiramatsu","doi":"10.3820/jjpe.27.34","DOIUrl":"https://doi.org/10.3820/jjpe.27.34","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75118574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"1．Millennial Medical Record Project: Secondary Use of Medical Data for Research and Development Based on the Next Generation Medical Infrastructure Law","authors":"Hiroyuki Yoshihara","doi":"10.3820/jjpe.27.3","DOIUrl":"https://doi.org/10.3820/jjpe.27.3","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78547799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Research Trends and Future Issues Related to Pre-analysis Data Preprocessing in Large-scale Real-World Data ―With the Goal of Using it in Clinical Research―","authors":"T. Iwao","doi":"10.3820/jjpe.27.e1","DOIUrl":"https://doi.org/10.3820/jjpe.27.e1","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85502994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"4．Vaccine in Crisis Management and National Defense","authors":"M. Imagawa","doi":"10.3820/JJPE.26.79","DOIUrl":"https://doi.org/10.3820/JJPE.26.79","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83581858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recommendations for Conducting Post-Marketing Database Study in Japan Based on the Critical Appraisal of Published Articles from Overseas Real-World Data (RWD) Analyses","authors":"Shinichi Matsuda, Nobuyuki Fukada, Masahito Oishi, Hiroaki Oka, Ryousuke Hara, Ai Kojima, Shunsuke Nakano, Katsuaki Motoyoshi, Igarashi Shigeki, Yuko Sasaki, Natsuko Kameyama, Kazuhiro Kubota","doi":"10.3820/JJPE.26.E4","DOIUrl":"https://doi.org/10.3820/JJPE.26.E4","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"48 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86044312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Joint statement to consolidate the pharmacovigilance systems for securing safety of the COVID-19 vaccine products","authors":"Anonymous","doi":"10.3820/jjpe.26.1","DOIUrl":"https://doi.org/10.3820/jjpe.26.1","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80711307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hideyuki Miyauchi, T. Komeda, M. Fujiwara, Takamichi Baba, S. Miyazawa, Y. Hongo, Y. Kitanishi, Eriko Ogura
laninamivir（0.91％（234／25,831）). Age-adjusted OR（vs baloxavir, as denomi-nator）and 95％ CIs was 1.125［0.961-1.317], 1.173［0.726-1.897］and 0.944［0.783-1.140］for oseltamivir, zanamivir and laninamivir, respectively. In addition, the proportion of death in patients with baloxavir （0.03％, n＝5）was comparable with that in oseltamivir（0.03％, n＝16), laninamivir（0.01％, n＝3), while there were no deaths in zanamivir due to the small number of patients. Conclusion ：In an observational study of Japanese acute hospital-based claims database, the frequency of severe events in influenza outpatients was comparable with that in other treatment groups, supporting that baloxavir may help prevent severe influenza as a new treatment option.
{"title":"Comparison of Hospitalization and Death Frequencies in Influenza Outpatients Treated with Baloxavir marboxil or Neuraminidase Inhibitors： an Observational Database Study","authors":"Hideyuki Miyauchi, T. Komeda, M. Fujiwara, Takamichi Baba, S. Miyazawa, Y. Hongo, Y. Kitanishi, Eriko Ogura","doi":"10.3820/JJPE.26.E2","DOIUrl":"https://doi.org/10.3820/JJPE.26.E2","url":null,"abstract":"laninamivir（0.91％（234／25,831）). Age-adjusted OR（vs baloxavir, as denomi-nator）and 95％ CIs was 1.125［0.961-1.317], 1.173［0.726-1.897］and 0.944［0.783-1.140］for oseltamivir, zanamivir and laninamivir, respectively. In addition, the proportion of death in patients with baloxavir （0.03％, n＝5）was comparable with that in oseltamivir（0.03％, n＝16), laninamivir（0.01％, n＝3), while there were no deaths in zanamivir due to the small number of patients. Conclusion ：In an observational study of Japanese acute hospital-based claims database, the frequency of severe events in influenza outpatients was comparable with that in other treatment groups, supporting that baloxavir may help prevent severe influenza as a new treatment option.","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82555664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：